Taking a Different Approach to Rare Epilepsies
RARECast - A podcast by RARECast - Giovedì
Categorie:
Meg Alexander, chief strategy officer of Ovid Therapeutics, discusses rare epilepsies, how the company’s experimental therapy soticlestat works, and the potential to apply the approach to other CNS conditions.
